ISSN: 0272-4391

Journal Home

Journal Guideline

Drug Development Research Q2 Unclaimed

John Wiley & Sons Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Drug Development Research is a journal indexed in SJR in Drug Discovery with an H index of 67. It has a price of 2950 €. It has an SJR impact factor of 0,672 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,672.

Drug Development Research focuses its scope in these topics and keywords: acetaminophen, heart, dynamic, drug, dppc, diseasesynthesis, diabetic, diabetes, correlation, dysfunction, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Drug Discovery (Q2)

Price

2950 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,672

SJR Impact factor

67

H Index

112

Total Docs (Last Year)

371

Total Docs (3 years)

6813

Total Refs

1390

Total Cites (3 years)

345

Citable Docs (3 years)

3.72

Cites/Doc (2 years)

60.83

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Biomolecules and Therapeutics Q2
PPAR Research Q2
Current Drug Targets Q2
Journal of Gene Medicine Q2
Current Gene Therapy Q2

Compare this journals